• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2020, Vol. 22 ›› Issue (1): 23-27.DOI: 10.3969/j.issn.1671-2587.2020.01.006

Previous Articles     Next Articles

The Effect of RhD Polypeptide to Inhibit the Reaction of RhD Antigen and Anti-D

WU Fan, ZHUANG Nai-bao, LIANG Shuang, et al   

  1. Shenzhen Blood Center,Shenzhen 518035
  • Received:2018-12-07 Online:2020-02-20 Published:2020-02-28

Abstract: Objective To evaluate the RhD polypeptide's inhibitory effect of the reaction of RhD antigen and anti-D. Methods RhD phage polypeptides were synthesized according to the amino acid sequence from phage display library screening. The physical and chemical properties and secondary structure of polypeptides were analyzed by bioinformatics. The effective polypeptides were verified by agglutination inhibition experiment using microcolumn gel (LISS and anti-human globulin). The effective blocking concentration of polypeptides was observed by using microscope to observe the agglutination reaction. The blocking effect of polypeptides was detected by flow cytometry. Results Peptide 4 is the most stable polypeptide. There are no random coil and antigenic in this polypeptide. Peptide 4 is able to inhibit the agglutination of IgG monoclonal anti-D and D+ cells in a concentration dependent manner and completely inhibit the reaction when the concentration reached 2.5 mg/50 μL. Conclusion Peptide 4 is the effective polypeptide. It is able to block the binding sites of anti-D and RhD antigen. The result has great significance to study the structure and function of RhD protein, to modify the antigen of RhD protein, and to improve the safety of clinical blood transfusion.

Key words: Rh blood group, Polypeptide, Anti-D antibody, D antigen

CLC Number: